Covid US: At least 628 ‘supervariant’ cases reported in 33 states

At least 645 cases of coronavirus variants from the United Kingdom, South Africa and Brazil have been reported in 33 countries.

Of the number, at least 626 are linked to the British variant, known as B 1.1.7. A DailyMail.com analysis of state and federal data revealed.

More than half of these cases have been reported in Florida and California, and there are two deaths associated with the tribe, one in New Jersey and one in Alabama.

Experts have warned that this variant is expected to become the dominant tribe in the US by March.

There are currently five cases of the B.1.351 variant, which was first detected in South Africa, of which three in Maryland and two in South Carolina.

In addition, two cases of the P.1 strain originating in Brazil have been identified in Minnesota.

This comes as cases in the US decreased by more than 50 percent, but deaths continue to increase with more than 5,000 deaths – the highest single day ever – recorded yesterday.

Due to the emergence of new variants, the US Food and Drug Administration (FDA) announced on Thursday that it is developing guidelines to help manufacturers of vaccines, medicines and test adaptations.

Acting Commissioner Janet Woodcock said that all three could work now, but that it was possible in the future.

“We must prepare for all opportunities,” she said in a call to reporters.

Woodcock said within the next few weeks that the FDA would give draft recommendations to help change products as needed.

Concerns have been raised over the past few weeks about variants of the virus, which seem more contagious.

The British variant was first discovered in the county of Kent, and now covers at least 61 cases in Britain.

According to most estimates, it is about 70 percent more contagious, but some studies suggest that it can be twice as contagious.

More moderate projections say its portability is only about 56 percent higher.

UK officials say the variant could be 30 to 40 percent more deadly, and so far there have been two deaths in the US associated with the variant.

The South African variant was also first announced in December and shares mutation with the British variants, as well as several others.

President Joe Biden is calling for a travel ban on people coming from South Africa in an attempt to stop the import of the new variant.

Dr Anthony Fauci, the country’s leading expert on infectious diseases, says the South African variant is the most worrying, as it can make the vaccines less effective due to mutations that help it develop ‘against’ antibodies that after vaccination or a previous COVID- 19.

The variant first attracted international attention when four travelers arrived in Tokyo from Manaus, Brazil, on January 2.

The variant has the same vein protein mutation as the highly transmissible versions found in Kent and South Africa – called N501Y – which better enables the acre to bind to receptors in the body.

Manaus, the largest city in the Amazon, was destroyed by COVID-19. The hospital’s oxygen is running low and Brazilian officials said it was in crisis.

Preliminary findings suggest that all five of the leading vaccine candidates offer some protection against the variants, but the grade differed.

Two weeks ago, Moderna announced that although the vaccine still works well enough to be protective against the South African variant, laboratory tests indicate that the antibodies caused by the shot may be 60 percent less potent in vitro against the virus ( in a cell culture, not a living animal or person).

Last week, the results of Novavax’s late study in the UK showed 95.6 per cent efficacy against the original circulating variant and 85.6 per cent against B 1.1.7.

But in the middle study of South Africa among about 4,000 participants, the Novavax shot was not as protective and it was found that it was only 49.4% effective for its variant, 501Y.V2.

An article released on Friday found that the vaccine developed by AstraZeneca and the University of Oxford is 74 percent effective against B 1.1.7.

However, the findings did not address the question of whether the protection extends to B.1.351.

Last week, dr. Fauci said at a press conference that the variants will become more dominant in the US by spring,

At the same briefing, Dr Rochelle Walensky, director of the CDC, said that every COVID-19 case in the US should be treated as if it were a case of the variant.